Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data
| Image |  |
|---|---|
| Description | scientific article published on 11 September 2018 |
| Author/s |
author: Frits van Rhee David Fajgenbaum |
| Publication date | September 11, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |